Russian Health Ministry Opposes Ban on E-Liquid Sales

Regulations by 2FIRSTS.ai

Nov.24.2023

Russian Health Ministry Opposes Ban on E-Liquid Sales

Russia's health ministry opposes a ban on the sale of e-liquids containing nicotine, citing potential infringement on citizens' health protection law.

According to a report by the Russian news agency TASS on November 24th, the Russian Ministry of Health has stated that it does not support a ban on the sale of e-liquids containing and not containing nicotine.

The department's submitted motion to withdraw the bill draft argues that it could potentially violate the concept of the Citizen Health Protection Act and result in legal conflicts and ambiguous interpretations.

According to reports, the Ministry of Health has also pointed out that by 2023, the estimated tax revenue from the production and import of nicotine-containing e-liquids in Russia will be 3.6 billion rubles.

The department predicts that tax revenues will increase in the coming years, reaching 12.1 billion, 12.6 billion, and 13.1 billion rubles in 2024, 2025, and 2026 respectively.

The Ministry of Health believes that if retail is banned, it will result in a loss of over 12 billion rubles (CNY 964 million) in tax revenue annually, with no clear sources for compensation at present.

References:

[1] "Известия": Минздрав выступил против запрета продажи жидкостей для вейпов

Also Read:

[1] Illegal Cigarette Sales in Russia: A Budget Loss

[2] Russian Students Launch Initiative to Collect Used E-Cigarettes

[3] Rising Sales of Small Cigars in Russia Due to Price Stability

[4] BAT Russian Division's Ownership Transferred to Abu Dhabi

#Russia #Health

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Research Report: E-Cigarette Device Market to Hit $34.29 Billion by 2031; Top Brands Now Hold Nearly Half the Share

Market research firm LP Information has released a global e-cigarette market report forecasting that the e-cigarette device market—including both disposable and reusable devices—will reach US$34.29 billion by 2031, with a 9.4% CAGR from 2025 to 2031.

Oct.16

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

Indonesia’s Statistics Agency: Bali Leads Nation in E-Cigarette Use; Urban Usage Climbing Sharply

Indonesia’s statistics agency (BPS) reports in its latest publication, Statistics of People’s Welfare 2025, that Bali has the highest share of daily e-cigarette users at 1.66%, followed by East Kalimantan (1.59%) and the Special Region of Yogyakarta (1.24%). Daily vaping prevalence is higher in urban areas (0.77%) than in rural areas (0.53%).

Oct.16

Spain to Tighten E-Cigarette Regulation: Public-Place Ban, Advertising Limits, Flavour Controls

Spain is advancing a 2025 Anti-Tobacco Law to align e-cigs with tobacco, tighten public-use/advertising/flavour rules, study phasing out disposables; cannabinoid, nicotine-free vapes are rising.